DevicePMAs@therightstef:P060004_S001 JSONTXT

{"project":"PMA_MER","denotations":[{"id":"T1","span":{"begin":0,"end":8},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25425"},{"id":"T2","span":{"begin":32,"end":37},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16782"},{"id":"T3","span":{"begin":52,"end":58},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C62103"},{"id":"T4","span":{"begin":75,"end":79},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43428"},{"id":"T5","span":{"begin":100,"end":108},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25285"},{"id":"T6","span":{"begin":115,"end":125},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C75958"},{"id":"T7","span":{"begin":126,"end":130},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C43428"},{"id":"T8","span":{"begin":154,"end":159},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25304"},{"id":"T9","span":{"begin":169,"end":177},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25285"},{"id":"T10","span":{"begin":211,"end":218},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25251"},{"id":"T11","span":{"begin":219,"end":224},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C16782"},{"id":"T12","span":{"begin":288,"end":297},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157203"},{"id":"T13","span":{"begin":386,"end":393},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25718"},{"id":"T14","span":{"begin":448,"end":455},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25564"},{"id":"T15","span":{"begin":506,"end":509},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25150"},{"id":"T16","span":{"begin":549,"end":555},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C30103"},{"id":"T17","span":{"begin":585,"end":589},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25609"},{"id":"T18","span":{"begin":585,"end":594},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C125217"},{"id":"T19","span":{"begin":590,"end":594},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29848"},{"id":"T20","span":{"begin":614,"end":620},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C25446"},{"id":"T21","span":{"begin":624,"end":630},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C64353"},{"id":"T22","span":{"begin":635,"end":643},"obj":"http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C63806"}],"text":"Approval for the mel 80 excimer laser system. This device uses an optical zone of 6.0 to 6.5 mm in diameter and a transition zone of 2.0 to 4.0 mm for a total ablation diameter of 10.0 mm, and is indicated for primary laser assisted in situ keratomileusis (lasik) treatments for: 1) the reduction or elimination of naturally-occurring hyperopia of less than or equal to +5.0 d with or without refractive astigmatism of \u003e +0.5 and \u003c= +3.0d, with a maximum mrse of +5.0d; 2) in patients who are 21 years of age or older; and 3) with documentation of stable manifest refraction over the past year as demonstrated by change in sphere and cylinder of \u003c= 0.5d."}

{"project":"consensus_PMA_Age_Indications","denotations":[{"id":"T5","span":{"begin":494,"end":518},"obj":"age_range"},{"id":"T8","span":{"begin":494,"end":496},"obj":"age_start"},{"id":"T7","span":{"begin":497,"end":502},"obj":"age_start_unit"},{"id":"T6","span":{"begin":513,"end":518},"obj":"age_end"}],"text":"Approval for the mel 80 excimer laser system. This device uses an optical zone of 6.0 to 6.5 mm in diameter and a transition zone of 2.0 to 4.0 mm for a total ablation diameter of 10.0 mm, and is indicated for primary laser assisted in situ keratomileusis (lasik) treatments for: 1) the reduction or elimination of naturally-occurring hyperopia of less than or equal to +5.0 d with or without refractive astigmatism of \u003e +0.5 and \u003c= +3.0d, with a maximum mrse of +5.0d; 2) in patients who are 21 years of age or older; and 3) with documentation of stable manifest refraction over the past year as demonstrated by change in sphere and cylinder of \u003c= 0.5d."}

{"project":"Age_blah","denotations":[{"id":"T1","span":{"begin":494,"end":496},"obj":"age_start"},{"id":"T2","span":{"begin":497,"end":502},"obj":"age_start_unit"},{"id":"T3","span":{"begin":513,"end":518},"obj":"age_end"},{"id":"T4","span":{"begin":494,"end":518},"obj":"age_range"}],"text":"Approval for the mel 80 excimer laser system. This device uses an optical zone of 6.0 to 6.5 mm in diameter and a transition zone of 2.0 to 4.0 mm for a total ablation diameter of 10.0 mm, and is indicated for primary laser assisted in situ keratomileusis (lasik) treatments for: 1) the reduction or elimination of naturally-occurring hyperopia of less than or equal to +5.0 d with or without refractive astigmatism of \u003e +0.5 and \u003c= +3.0d, with a maximum mrse of +5.0d; 2) in patients who are 21 years of age or older; and 3) with documentation of stable manifest refraction over the past year as demonstrated by change in sphere and cylinder of \u003c= 0.5d."}

{"project":"PMA_age_indications","denotations":[{"id":"T8","span":{"begin":494,"end":496},"obj":"age_start"},{"id":"T5","span":{"begin":494,"end":518},"obj":"age_range"},{"id":"T7","span":{"begin":497,"end":502},"obj":"age_start_unit"},{"id":"T6","span":{"begin":513,"end":518},"obj":"age_end"}],"text":"Approval for the mel 80 excimer laser system. This device uses an optical zone of 6.0 to 6.5 mm in diameter and a transition zone of 2.0 to 4.0 mm for a total ablation diameter of 10.0 mm, and is indicated for primary laser assisted in situ keratomileusis (lasik) treatments for: 1) the reduction or elimination of naturally-occurring hyperopia of less than or equal to +5.0 d with or without refractive astigmatism of \u003e +0.5 and \u003c= +3.0d, with a maximum mrse of +5.0d; 2) in patients who are 21 years of age or older; and 3) with documentation of stable manifest refraction over the past year as demonstrated by change in sphere and cylinder of \u003c= 0.5d."}

{"project":"updated_tagging_age_PMA_annotations","denotations":[{"id":"T5","span":{"begin":494,"end":518},"obj":"age_range"},{"id":"T6","span":{"begin":513,"end":518},"obj":"age_end"},{"id":"T7","span":{"begin":497,"end":502},"obj":"age_start_unit"},{"id":"T8","span":{"begin":494,"end":496},"obj":"age_start"}],"text":"Approval for the mel 80 excimer laser system. This device uses an optical zone of 6.0 to 6.5 mm in diameter and a transition zone of 2.0 to 4.0 mm for a total ablation diameter of 10.0 mm, and is indicated for primary laser assisted in situ keratomileusis (lasik) treatments for: 1) the reduction or elimination of naturally-occurring hyperopia of less than or equal to +5.0 d with or without refractive astigmatism of \u003e +0.5 and \u003c= +3.0d, with a maximum mrse of +5.0d; 2) in patients who are 21 years of age or older; and 3) with documentation of stable manifest refraction over the past year as demonstrated by change in sphere and cylinder of \u003c= 0.5d."}